Evidence map›Paper›PMID 40573399›Full record

ArticleViruses2025

An Evaluation of the Anti-Rabies Effect of Bufotenine in Murine Rabies Models to Determine Its Mechanism of Action.

Patrícia Mariano Cruz Pereira, Andréa de Cássia Rodrigues Silva, Karen Miyuki Asano, Adriana da Costa Neves, Juliana Mozer Sciani, Daniel Carvalho Pimenta, Hugo Vigerelli

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Patrícia Mariano Cruz PereiraLaboratory of Biochemistry and Biophysics, Butantan Institute, São Paulo 05503-900, SP, Brazil.
Andréa de Cássia Rodrigues SilvaLaboratory of Rabies Diagnostic, Serology, Pasteur Institute, São Paulo 01311-000, SP, Brazil.ORCID 0009-0000-8470-9591
Karen Miyuki AsanoLaboratory of Rabies Diagnostic, Serology, Pasteur Institute, São Paulo 01311-000, SP, Brazil.
Adriana da Costa NevesLaboratory of Genetics, Butantan Institute, São Paulo 05503-900, SP, Brazil.
Juliana Mozer ScianiPrograma de Pós-Graduação em Toxinologia, Butantan Institute, São Paulo 05503-900, SP, Brazil.ORCID 0000-0001-7213-206X
Daniel Carvalho PimentaLaboratory of Biochemistry and Biophysics, Butantan Institute, São Paulo 05503-900, SP, Brazil.ORCID 0000-0003-2406-0860
Hugo VigerelliLaboratory of Biochemistry and Biophysics, Butantan Institute, São Paulo 05503-900, SP, Brazil.ORCID 0000-0002-8197-2260

Funding

Butantan FoundationNational Council for Scientific and Technological Development 305525/2023-9
6 · The paper itself

Abstract

Molecules from animals or plant species have been investigated with the aim of treating diseases of epidemiological importance, such as rabies, which is a viral, acute, and infectious disease with approximately 100% lethality. Rabies has been one of the main causes of death in humans concerning infectious diseases. This work investigated the action and preliminary mechanisms of the alkaloid bufotenine in an in vivo model with the rabies virus. A wild-type virus was titrated and injected into mice for the determination of DL50 in the presence or absence of bufotenine. The results reveal that bufotenine has possible action in modulating the immune response of the studied host, suggesting interference in delaying symptom manifestation. Regarding the histological analysis of the CNS of the animals, bufotenine possibly prevented the presence of mononuclear cell inflammatory infiltrate in the meninx's region compared to the positive control and possibly contributed to reducing neuronal degeneration. The use of the bufotenine extracted from the seed of white angico, a plant representative of Brazilian flora, contributed to antiviral activity with effects on the immunological aspects of the host infected by the rabies virus.

Indexed as

Antiviral AgentsRabiesRabies virusAnimalsDisease Models, AnimalMiceAntiviral Agentsalkaloidantiviralbufotenineimmune systemrabies virus

Identifiers

PMID40573399
PMCPMC12197729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.